Commercialization of COVID-19 Vaccines, Treatments, and Tests: Implications for Access and Coverage February 6, 2024 Issue Brief With the depletion of the federal-purchased supply of COVID-19 vaccines, treatments and tests following the end of the public health emergency, this resource provides an overview of the implications of these changes for access to people covered by Medicare, Medicaid and private insurance, as well as those who are uninsured.
FAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program January 31, 2024 Issue Brief The Centers for Medicare & Medicaid Services (CMS) recently issued initial guidance describing CMS’s plans for implementation of the new Medicare Drug Price Negotiation Program, which was established by the Inflation Reduction Act. These FAQs address several questions related to Medicare’s drug price negotiation program and how CMS intends to implement the new program, with a focus on the details that apply for 2026, the first year that negotiated prices will be available under this new program.
10 Reasons Why Medicare Advantage Enrollment is Growing and Why It Matters January 30, 2024 Issue Brief This issue briefs lays out 10 reasons why Medicare Advantage enrollment has been growing and why we can expect more growth in the years to come.
Medicaid: What to Watch in 2024 January 30, 2024 Issue Brief As the start of 2024, many issues are at play that will affect Medicaid coverage, financing, and access. This issue brief provides context for these Medicaid issues and highlights key issues to watch in the year ahead.
What to Watch in 2024: The Latest Health Cost and Affordability Issues and Trends January 24, 2024 News Release While issues of health care costs and affordability may not be at the forefront of this year’s election issues, they remain a major concern among the public. About a quarter of Americans say they or a family member struggled to pay their medical bills just in the past year, and…
Medicaid and State Financing: What to Watch in Upcoming State Budget Debates January 22, 2024 Issue Brief State legislatures are currently gathering to develop new budgets for state fiscal year (FY) 2025. Heading into this budget cycle, state fiscal conditions are shifting, with state revenues starting to decline following steep revenue growth during the pandemic. This issue brief examines trends in state fiscal conditions and discusses how state budgets and macroeconomic conditions may affect individuals and state Medicaid programs.
The Two Health Care Cost Crises January 18, 2024 From Drew Altman In this column, KFF President and CEO Drew Altman explores the nation’s twin health cost crises of affordability, especially for people who are sick and need a lot of health care, and national health spending, and why the solutions often work at cross purposes.
What Are the Implications of the Recent Elimination of the Medicaid Prescription Drug Rebate Cap? January 16, 2024 Blog This policy watch explains the Medicaid prescription drug rebate cap, examines how many drugs might be impacted, and explores the implications of recent manufacturer responses for Medicaid programs and enrollees.
What to Know About the FDA’s Recent Decision to Allow Florida to Import Prescription Drugs from Canada January 12, 2024 Blog Florida’s plan to import certain prescription drugs from Canada represents the first time the Food and Drug Administration (FDA) has granted authority for a state to safely import prescription drugs from another country. This policy watch analysis unpacks some frequently asked questions related to state of Florida’s importation plan, including potential obstacles to implementation, who will benefit from any savings, and what types of drugs will (and will not) qualify for importation.
Health Coverage by Race and Ethnicity, 2010-2022 January 11, 2024 Issue Brief This brief examines trends in health coverage by race/ethnicity between 2010 through 2022, shows how eligibility for coverage among the remaining uninsured varies by race/ethnicity, and highlights issues in addressing coverage disparities looking ahead.